🇺🇸 FDA
Patent

US 9073875

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

granted A61KA61K31/4192A61K31/4439

Quick answer

US patent 9073875 (Compounds useful as inhibitors of indoleamine 2,3-dioxygenase) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61K, A61K31/4192, A61K31/4439, A61K45/06, A61P